InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Pellegrini Niamh Louise, Dirigeant. Insider active across 2 companies, notably NEVRO CORP. Cumulatively, 7 disclosures have been logged. The latest transaction was disclosed on 16 June 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations7 total
08,400 shares0
Common Stock
SEC:0000950103-22-010953:0·
€130,0212,031 shares@ €64.018312.8% of flow
Common Stock
SEC:0001567619-22-006438:0·
026,069 shares0
Common Stock
SEC:0001567619-22-006143:0·
04,172 shares0
Common Stock
SEC:0000950103-21-012267·
04,172 shares0
Common Stock
SEC:0000950103-21-012267:0·
€441,6644,366 shares@ €101.1599100.0% of flow
Common Stock
SEC:0001567619-21-014908·
€441,6644,366 shares@ €101.159943.6% of flow
Common Stock
SEC:0001567619-21-014908:0·
7 of 7 declarations
About Pellegrini Niamh Louise
Niamh Louise Pellegrini is the Chief Commercial Officer and Director at NEVRO CORP and Acutus Medical, Inc. She oversees business and product development strategies for these medical technology companies. Niamh is committed to improving patient outcomes through innovative solutions.
